Percutaneous Impella RP use for refractory right heart failure in adolescents and young adults-A multicenter U.S. experience.
Athar M QureshiMariel E TurnerWilliam O'NeillSusan W DenfieldNima AghiliAmit BadiyeRadhakrishan GandhiBehnam TehraniGeorge ChangJared K OyamaShashank SinhaNicolas BrozziBrian H MorrayPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
In this multicenter experience, the Impella RP device was found to be efficacious and safe when used in adolescents and young adults. Further studies are warranted to identify suitable young/pediatric candidates for Impella RP therapy for right heart failure.